Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Mark R. Hake, CFA

Teva Pharmaceuticals Stock Has Unusual Call Options Activity After Its Q1 Results

Teva Pharmaceuticals (TEVA), the generic drug maker based in Israel, posted good Q1 results today with revenue beating analysts' forecasts. Despite earnings falling short of projections, Teva reaffirmed its forecast for significant free cash flow in 2024. 

As a result, TEVA stock is 13% higher to $15.81 per share in morning trading. That has also led to unusual call options activity today based on a Barchart report. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.